Efficient Biosynthesis of Lacto‑N‑Biose I, a Building Block of Type I Human Milk Oligosaccharides, by a Metabolically Engineered Escherichia coli

• Published in: Journal of agricultural and food chemistry Vol. 72; no. 11; pp. 5860 - 5866
• Main Authors: Tao, Mengting, Yang, Longhao, Zhao, Chunhua, Zhang, Wenli, Zhu, Yingying, Mu, Wanmeng
• Format: Journal Article
• Language: English
• Published: United States American Chemical Society 20.03.2024
• Subjects: Acetylglucosamine - analogs & derivatives; Biotechnology and Biological Transformations; Escherichia coli - genetics; Escherichia coli - metabolism; Humans; Infant; Lactose - metabolism; Milk, Human - metabolism; Oligosaccharides - metabolism; human milk oligosaccharides; metabolic engineering; lacto-N-tetraose; lacto-N-biose I; biosynthesis
• ISSN: 0021-8561; 1520-5118
• DOI: 10.1021/acs.jafc.4c00153

Lacto-N-biose I (LNB), termed a Type 1 disaccharide, is an important building block of human milk oligosaccharides. It shows promising prebiotic activity by stimulating the proliferation of many gut-associated bifidobacteria and thus displays good potential in infant foods or supplements. Enzymatic and microbial approaches to LNB synthesis have been studied, almost all of which involve glycosylation of LNB phosphorylase as the final step. Herein, we report a new and easier microbial LNB synthesis strategy through the route “lactose → lacto-N-triose II (LNTri II) → lacto-N-tetraose (LNT) → LNB”. A previously constructed LNT-producing Escherichia coli BL21­(DE3) strain was engineered for LNB biosynthesis by introducing Bifidobacterium bifidum LnbB. LNB was efficiently produced, accompanied by lactose regeneration. Genomic integration of key pathway genes related to LNTri II and LNT synthesis was performed to enhance LNB titers. The final engineered strain produced 3.54 and 26.88 g/L LNB by shake-flask and fed-batch cultivation, respectively.